Biocontrol agent for suppressing pythium damping-off in crops
A bacterial biocontrol agent developed to suppress Pythium spp., reducing plant diseases such as root rot and damping-off, offering a sustainable alternative to chemical pesticides.
Overview
This innovative biocontrol agent offers an environmentally friendly solution to combat Pythium spp., soilborne pathogens that cause significant crop diseases like root rot and damping-off. By utilizing a specific bacterial strain with antagonistic properties, this solution aims to provide an effective alternative to chemical pesticides, promoting sustainable agricultural practices and reducing environmental impacts.
Technical specifications
The biocontrol agent works by isolating and utilizing a bacterial strain that exhibits antagonistic activity against Pythium spp. The mechanisms include:
- Competition for nutrients: The bacterial strain competes with Pythium for vital nutrients, inhibiting its growth.
- Antibiosis: The strain produces substances that are toxic to Pythium, further suppressing its development.
- Production of lytic enzymes: These enzymes break down the cell walls of Pythium, effectively controlling its spread.
The effectiveness of this biocontrol agent has been evaluated under both controlled laboratory conditions and field trials, demonstrating its potential as a reliable solution for farmers.
Technology readiness level
The technology is currently at Technology Readiness Level 3, having been validated in laboratory settings and field conditions. Further development and mass production require co-development and licensing partnerships for commercial deployment.
About University of Worcester
The University of Worcester is a modern public university with a professional, applied focus and a growing research profile. Industry partners engage through city-center facilities, collaboration spaces, and consultancy pathways that make it easy to scope, prototype, and evaluate. Integration with regional NHS hospital trusts and community providers supports clinical studies, while human performance facilities, environmental monitoring units, and data resources enable real-world testing. Research is supported by competitive funding from UK Research and Innovation, Innovate UK, the National Institute for Health and Care Research, and charitable foundations. An enterprise and IP team manages contracts, Knowledge Transfer Partnerships, licensing, and spinout support.
delivered to your inbox.